zh-twzhen
zh-twzhen

NEWS

合一生技股份有限公司 / 2022 / The Annual General Shareholders’ Meeting approved the removal of non-competition restriction on the newly-elected director.

The Annual General Shareholders’ Meeting approved the removal of non-competition restriction on the newly-elected director.

2022-05-24

Published Date:2022-05-24

Original Link:https://www.onenessbio.com/en/news_detail167_2.htm

No 3 Date of announcement 2022/05/24 Time of announcement 19:17:23
Subject The Annual General Shareholders’ Meeting approved the removal of non-competition restriction on the newly-elected director.
To which item it meets paragraph 21 Date of events 2022/05/24
Statement
  1. Date of the shareholders’ meeting resolution:2022/05/24
  2. Name and title of the managerial officer with permission to engage in competitive conduct:Lin, Yi-Fu, Director of the board
  3. Items of competitive conduct in which the officer is permitted to engage:
    1.Independent Director of Taishin Holdings
    2.Independent Director of Taishin Bank
    3.Independent Director of Swissray Global Healthcare Holding Ltd.
    4.Independent Director of Nanya Plastics
    5.Independent Director of PAN German Universal Motors Ltd.
  4. Period of permission to engage in the competitive conduct:During the tenure of the director.
  5. Circumstances of the resolution (please describe the results of voting in accordance with Article 209 of the Company Act):
    Total number of shares represented by attending shareholders: 251,642,039,
    The number of voting for agreement:241,580,903,
    The number of voting for disagreement:1,820,879,
    The numner of invalid votes:0,
    The number of votes abandoned and absence:8,240,257
    96% of total number of shares represented by attending shareholders approve the proposal.The proposal is approved upon voting.
  6. If the permitted competitive conduct belongs to the operator of a mainland China enterprise, the name and title of the directors (if it is not the operator of a mainland China enterprise, please enter “N/A” below):NA
  7. Company name of the mainland China enterprise and the officer’s position in the enterprise:NA
  8. Address of the mainland China enterprise:NA
  9. Operations of the mainland China enterprise:NA
  10. Impact on the company’s finance and business:NA
  11. If the directors have invested in the mainland China enterprise, the monetary amount of the investment and their shareholding ratio:NA
  12. Any other matters that need to be specified:Lin, Yi-Fu has not served as independent director of Swissray Global Healthcare Holding Ltd. since April 29, 2022.